Literature DB >> 31278380

Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.

Jonathan E Lu1, R Joel Welch1, Kavita K Mishra2, Inder K Daftari2, Susanna S Park3.   

Abstract

BACKGROUND/
OBJECTIVE: The success of proton beam treatment (PBT) in uveal melanoma depends in part on the accuracy of tumour localisation. This study determined if using ultrasonography (US) to measure the distance between tumour margin and tantalum ring (DTR) in PBT planning improves local treatment success when compared with using intraoperative transillumination (TI) alone.
METHODS: Retrospective analysis of patients with uveal melanoma treated at one centre between January 2006 and June 2017 with ≥12-month follow-up (or until treatment failure). Local tumour control was compared among study groups based on methods for measuring DTR: Group 1 (TI alone), Group 2A (postoperative US alone) and Group 2B (combination).
RESULTS: Fifty-four eyes (54 patients) with uveal melanomas were included: Group 1 (22 eyes, 41%), Group 2A (11 eyes, 20%) and Group 2B (21 eyes, 39%). Mean age at diagnosis was 64 years [median 66 years, range 23-86 years]. Fifty tumours (93%) involved the choroid, while four involved the ciliary body (7%). In Group 2B, PBT treatment was based on the DTR obtained using US; DTR differed between TI and US by ≥1 mm for 25 rings in 16 eyes and ≥2 mm for 12 rings in 7 eyes. Five-year Kaplan-Meier estimate revealed a difference in local treatment success between Groups 1 and 2, (0.82 vs. 1.0, p = 0.02) with no difference in overall survival estimate, (0.85 vs. 0.83, p = 0.8).
CONCLUSIONS: US can be used to measure DTR in PBT planning for uveal melanoma. This may improve accuracy of tumour localisation and improve local treatment success.

Entities:  

Year:  2019        PMID: 31278380      PMCID: PMC7002621          DOI: 10.1038/s41433-019-0512-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

1.  Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.

Authors:  Kavita K Mishra; Jeanne M Quivey; Inder K Daftari; Vivian Weinberg; Tia B Cole; Kishan Patel; Joseph R Castro; Theodore L Phillips; Devron H Char
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

2.  Evidence-based estimates of outcome in patients irradiated for intraocular melanoma.

Authors:  Evangelos Gragoudas; Wenjun Li; Michael Goitein; Anne Marie Lane; John E Munzenrider; Kathleen M Egan
Journal:  Arch Ophthalmol       Date:  2002-12

3.  Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.

Authors:  Simone Marnitz; Dino Cordini; Rolf Bendl; Arne-Jörn Lemke; Jens Heufelder; Ioannis Simiantonakis; Heinz Kluge; Nikolaos E Bechrakis; Michael H Foerster; Wolfgang Hinkelbein
Journal:  Strahlenther Onkol       Date:  2006-07       Impact factor: 3.621

4.  Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma.

Authors:  Melinda Y Chang; Mitchell Kamrava; D Jeffrey Demanes; Min Leu; Nzhde Agazaryan; James Lamb; Joel N Moral; Robert Almanzor; Tara A McCannel
Journal:  Ophthalmology       Date:  2012-01-31       Impact factor: 12.079

5.  Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.

Authors:  Kavita K Mishra; Inder K Daftari; Vivian Weinberg; Tia Cole; Jeanne M Quivey; Joseph R Castro; Theodore L Phillips; Devron H Char
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-23       Impact factor: 7.038

6.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Authors:  Carol L Shields; Minoru Furuta; Archana Thangappan; Saya Nagori; Arman Mashayekhi; David R Lally; Cecilia C Kelly; Danielle S Rudich; Anand V Nagori; Oojwala A Wakade; Sonul Mehta; Lauren Forte; Andrew Long; Elaina F Dellacava; Bonnie Kaplan; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-08

7.  Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.

Authors:  Alexei L Polishchuk; Kavita K Mishra; Vivian Weinberg; Inder K Daftari; Jacqueline M Nguyen; Tia B Cole; Jeanne M Quivey; Theodore L Phillips; Devron H Char
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-23       Impact factor: 7.038

8.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.

Authors: 
Journal:  Arch Ophthalmol       Date:  2006-12

9.  Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients.

Authors:  Carol L Shields; Jacqueline Cater; Jerry A Shields; Aning Chao; Hatem Krema; Miguel Materin; Luther W Brady
Journal:  Arch Ophthalmol       Date:  2002-07

10.  Relative survival rates after alternative therapies for uveal melanoma.

Authors:  J M Seddon; E S Gragoudas; K M Egan; R J Glynn; S Howard; R G Fante; D M Albert
Journal:  Ophthalmology       Date:  1990-06       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.